M.D.C. (NYSE:MDC) Now Covered by StockNews.com

StockNews.com assumed coverage on shares of M.D.C. (NYSE:MDC) in a report released on Tuesday. The brokerage set a “hold” rating on the construction company’s stock.

A number of other equities analysts also recently commented on the company. Evercore ISI downgraded M.D.C. from an “outperform” rating to an “in-line” rating and lifted their price target for the stock from $57.00 to $63.00 in a research note on Wednesday, January 31st. Raymond James restated a “market perform” rating on shares of M.D.C. in a research note on Wednesday, February 7th. One research analyst has rated the stock with a sell rating and five have issued a hold rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $52.13.

M.D.C. Stock Up 0.1 %

Shares of M.D.C. stock opened at $62.87 on Tuesday. The business has a 50-day moving average of $62.62 and a 200-day moving average of $51.49. The company has a debt-to-equity ratio of 0.50, a current ratio of 9.76 and a quick ratio of 3.92. The company has a market capitalization of $4.72 billion, a PE ratio of 11.91 and a beta of 1.54. M.D.C. has a 1-year low of $36.47 and a 1-year high of $63.00.

M.D.C. (NYSE:MDC) last announced its earnings results on Tuesday, January 30th. The construction company reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.50 by $0.06. The company had revenue of $1.31 billion during the quarter, compared to the consensus estimate of $1.29 billion. M.D.C. had a return on equity of 12.32% and a net margin of 8.64%. The company’s revenue was down 11.9% on a year-over-year basis. During the same period last year, the firm earned $1.08 earnings per share. As a group, equities analysts forecast that M.D.C. will post 5.38 EPS for the current fiscal year.

Insider Activity

In other news, Director David E. Blackford sold 6,200 shares of M.D.C. stock in a transaction that occurred on Monday, March 11th. The stock was sold at an average price of $62.69, for a total transaction of $388,678.00. Following the sale, the director now owns 13,534 shares of the company’s stock, valued at $848,446.46. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 23.30% of the company’s stock.

Institutional Investors Weigh In On M.D.C.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. WealthPLAN Partners LLC bought a new stake in M.D.C. during the fourth quarter worth approximately $992,000. Tudor Investment Corp Et Al raised its holdings in M.D.C. by 0.8% during the third quarter. Tudor Investment Corp Et Al now owns 117,754 shares of the construction company’s stock worth $4,855,000 after purchasing an additional 977 shares in the last quarter. Alps Advisors Inc. bought a new stake in M.D.C. during the third quarter worth approximately $1,803,000. Swiss National Bank raised its holdings in M.D.C. by 22.7% during the third quarter. Swiss National Bank now owns 136,643 shares of the construction company’s stock worth $5,634,000 after purchasing an additional 25,300 shares in the last quarter. Finally, Duality Advisers LP raised its holdings in M.D.C. by 574.9% during the third quarter. Duality Advisers LP now owns 29,884 shares of the construction company’s stock worth $1,232,000 after purchasing an additional 25,456 shares in the last quarter. Institutional investors own 88.08% of the company’s stock.

M.D.C. Company Profile

M.DC Holdings, Inc, through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name.